Literature DB >> 22552383

Long-term improvement of oxidative stress via kidney transplantation ameliorates serum sulfatide levels.

Yuji Kamijo1, Lixuan Wang, Akihiro Matsumoto, Takero Nakajima, Koji Hashimoto, Makoto Higuchi, Mamoru Kyogashima, Toshifumi Aoyama, Atsushi Hara.   

Abstract

BACKGROUND: Oxidative stress (OS) is a strong risk factor for cardiovascular disease (CVD). The incidence of CVD is lower among kidney transplantation (KT) recipients than hemodialysis patients, and the reduction in OS may be one reason for this difference. Recently, serum sulfatides were recognized as a candidate inhibitory factor of CVD affected by OS. However, the long-term changes in OS and serum sulfatide levels in KT recipients are unknown.
METHODS: We investigated the long-term changes in a serum OS marker, malondialdehyde (MDA), and the serum sulfatide levels in 17 KT recipients. Multiple regression analysis was used to analyze the factors correlated with serum sulfatide levels.
RESULTS: The high serum levels of MDA in the KT recipients decreased dramatically but were still high 1 year after KT surgery. MDA levels decreased further and reached near-normal levels more than 3 years after the surgery. Similarly, over the same 3 years, the low serum sulfatide levels increased to near-normal levels, reaching saturation. Multiple regression analysis showed that the most significant factors influencing serum sulfatide levels were MDA and total cholesterol content.
CONCLUSIONS: The current results show that over the long term, the internal improvement brought about by successful KT can normalize OS. Oxidative normalization was significantly correlated with the restoration of serum sulfatide levels, which were also influenced by lipoprotein metabolism. The amelioration of serum sulfatide levels might contribute to the low incidence of CVD in KT recipients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22552383     DOI: 10.1007/s10157-012-0634-2

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  30 in total

Review 1.  Impact of dyslipidaemia in renal transplant recipients.

Authors:  C Wanner; T Quaschning; K Weingärnter
Journal:  Curr Opin Urol       Date:  2000-03       Impact factor: 2.309

2.  Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine.

Authors:  T Aoyama; S Yamano; D J Waxman; D P Lapenson; U A Meyer; V Fischer; R Tyndale; T Inaba; W Kalow; H V Gelboin
Journal:  J Biol Chem       Date:  1989-06-25       Impact factor: 5.157

3.  Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients.

Authors:  Edith M Simmons; Anthony Langone; M Tugrul Sezer; John P Vella; Peter Recupero; Jason D Morrow; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Transplantation       Date:  2005-04-27       Impact factor: 4.939

4.  Normalization of oxidative stress parameters after kidney transplant is secondary to full recovery of renal function.

Authors:  F Antolini; F Valente; D Ricciardi; R M Fagugli
Journal:  Clin Nephrol       Date:  2004-08       Impact factor: 0.975

5.  A novel disease with deficiency of mitochondrial very-long-chain acyl-CoA dehydrogenase.

Authors:  T Aoyama; Y Uchida; R I Kelley; M Marble; K Hofman; J H Tonsgard; W J Rhead; T Hashimoto
Journal:  Biochem Biophys Res Commun       Date:  1993-03-31       Impact factor: 3.575

6.  The existence of galactosylceramide I3-sulfate in serums of various mammals and its anticoagulant activity.

Authors:  X H Zhu; A Hara; T Taketomi
Journal:  J Biochem       Date:  1991-08       Impact factor: 3.387

7.  Acute kidney injury induced by protein-overload nephropathy down-regulates gene expression of hepatic cerebroside sulfotransferase in mice, resulting in reduction of liver and serum sulfatides.

Authors:  Xiaowei Zhang; Takero Nakajima; Yuji Kamijo; Gang Li; Rui Hu; Reiji Kannagi; Mamoru Kyogashima; Toshifumi Aoyama; Atsushi Hara
Journal:  Biochem Biophys Res Commun       Date:  2009-11-04       Impact factor: 3.575

8.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

9.  Sulfatide prolongs blood-coagulation time and bleeding time by forming a complex with fibrinogen.

Authors:  A Hara; K Uemura; T Taketomi
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

Review 10.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

View more
  5 in total

1.  Impact of chronic kidney dysfunction on serum Sulfatides and its metabolic pathway in mice.

Authors:  Yosuke Yamada; Makoto Harada; Koji Hashimoto; Ran Guo; Takero Nakajima; Toshihide Kashihara; Mitsuhiko Yamada; Toshifumi Aoyama; Yuji Kamijo
Journal:  Glycoconj J       Date:  2018-12-10       Impact factor: 2.916

2.  Peroxisome proliferator-activated receptor α mediates enhancement of gene expression of cerebroside sulfotransferase in several murine organs.

Authors:  Takero Nakajima; Yuji Kamijo; Huang Yuzhe; Takefumi Kimura; Naoki Tanaka; Eiko Sugiyama; Kozo Nakamura; Mamoru Kyogashima; Atsushi Hara; Toshifumi Aoyama
Journal:  Glycoconj J       Date:  2012-10-13       Impact factor: 2.916

3.  Infectious episodes lead to the oxidative stress response after lung transplantation.

Authors:  Takuro Miyazaki; Naoya Yamasaki; Tomoshi Tsuchiya; Keitaro Matsumoto; Katsunori Takagi; Hiroo Izumino; Takeshi Nagayasu
Journal:  Am J Case Rep       Date:  2015-04-30

4.  Chronic kidney disease, kidney transplantation and oxidative stress: a new look to successful kidney transplantation.

Authors:  Hossein Tabriziani; Michael S Lipkowitz; Nhan Vuong
Journal:  Clin Kidney J       Date:  2017-08-16

5.  Serum Sulfatide Levels as a Biomarker of Active Glomerular Lesion in Patients with Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: A Single Center Pilot Study.

Authors:  Makoto Harada; Takero Nakajima; Yosuke Yamada; Daiki Aomura; Akinori Yamaguchi; Kosuke Sonoda; Naoki Tanaka; Koji Hashimoto; Yuji Kamijo
Journal:  J Clin Med       Date:  2022-01-30       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.